Literature DB >> 6277844

In-vitro activity of Sch 29482, MK 0787, ceftriaxone and seven other antimicrobials against 840 separate clinical isolates.

C L Pierson, D R Schaberg, F R Fekety, K D McClatchey.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6277844     DOI： 10.1093/jac/9.suppl_c.79

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  5 in total

1.  Another look at trimethoprim-sulfamethoxazole: its role in parenteral therapy.

Authors:  F R Sattler; J S Remington
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

2.  Subinhibitory concentrations of imipenem induce increased resistance to methicillin and imipenem in vitro in methicillin-resistant Staphylococcus aureus.

Authors:  B A Forbes; K D McClatchey; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 3.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

4.  Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.

Authors:  S R Crider; S D Colby
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

5.  Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid.

Authors:  M J Zervos; D R Schaberg
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.